CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $210,363 | -20.1% | 7,644 | -1.5% | 0.05% | -22.2% |
| Q2 2023 | $263,399 | -5.7% | 7,763 | 0.0% | 0.06% | -13.7% |
| Q1 2023 | $279,318 | -22.4% | 7,763 | -3.9% | 0.07% | -30.5% |
| Q4 2022 | $359,909 | +58.6% | 8,075 | 0.0% | 0.10% | +64.1% |
| Q3 2022 | $227,000 | +2.3% | 8,075 | -2.0% | 0.06% | 0.0% |
| Q2 2022 | $222,000 | -21.0% | 8,240 | 0.0% | 0.06% | +3.2% |
| Q1 2022 | $281,000 | – | 8,240 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |